Pranav Bhuvanagiri, Amyn Macknojia*, Ishaan Ali and Ashmit Bhatnagar

Clements High School, Sugar Land, Houston, Texas, USA

*Corresponding Author: Amyn Macknojia, Clements High School, Sugar Land, Houston, Texas, USA.

Received: July 06, 2021; Published: July 21, 2021

Abstract

  Throughout our existence, technology has served to enhance the average quality of life for us humans. Each year, decade, and century always seems to outshine the previous in terms of technological breakthroughs. Such can be said within the world of medicine. A century ago, major wounds were solved by amputation - the removal of damaged parts of the body to prevent blood loss or infection. And only some hundred years later, major wounds can be effectively treated via advanced surgeries and even the recent advent of transplantation. Transplantation is an arduous and complex process that involves exchanging an organ from one body to another. Transplantation has many elements too. Evidently, the most essential being the healthy organ that would be transplanted. Finding an organ as a transplant is a daunting process characterized by lengthy wait times, rigorous formalities, and priceless fees. Not only is it incredibly challenging to find a healthy organ but even more tough to obtain an organ that is compatible with your body. Not to mention, transplants can cost hundreds of thousands of dollars - most spent on acquiring these organs. Even all this assumes the ability to find quick and easy access to a donor, which in reality, is far from the case, which explains the urgency and the seeming irresolvability of the problem at hand. People are forced to wait for years in the seemingly endless search for a donor whilst their conditions continue to worsen and their life is constantly threatened. According to the Health Resources and Services Administration, there are upwards of 107,000 individuals on the national transplant waiting list, and this list is only expanding as one more man, woman, or child sees their name added to the list every nine minutes. What’s worse? Unfortunately, 17 people die each day awaiting the rare opportunity of organ transplants, which despite being a tough pill to swallow, serves to expose the horrendously outrageous magnitude of this searing dilemma. Not only is this “list-system”, which stakes its functionality on donations and bureaucracy, antiquated and inefficient, the medical procedure itself is prone to tragic failures. Basically, as miraculous as it is for someone on the waitlist to even see their number called, it is even more improbable that they survive the medical operation. All that paired with the vast cost which comes with any medical procedure of this magnitude means a solution is necessary. Ultimately, just like hundreds of years ago, when humans thought of and invented new technologies to combat biological problems, humans are doing the same now, in hopes of finding a cheaper, efficient, and most importantly healthier artificial solution with the aid of their most critical and unique ally: technology.

Keywords: Bioprinting; Medicine; Organ Transplants

References

1. Anversa Piero., et al. “Regenerating New Heart with Stem Cells”. The Journal of Clinical Investigation 1 (2013)62-70.
2. Badylak Stephen F., et al. “RETRACTED: Engineered Whole Organs and Complex Tissues”. The Lancet9819 (2012): 943-952.
3. Campbell K H S., et al. “Sheep Cloned by Nuclear Transfer from a Cultured Cell Line”. Nature News 380 (1996): 64-66.
4. Cascalho Marilia., et al. “Xenotransplantation and the Future of Renal Replacement” (2004).
5. Cascalho Marilia and Jeffrey L Platt. “New Technologies for Organ Replacement and Augmentation”. Mayo Clinic Proceedings (2011).
6. Crotti Nancy. “Patenting the 3D Bioprinting Innovations That Combat COVID-19”. Medical Design and Outsourcing 7 Jan. (2021).
7. Hammerman Marc R. “Transplantation of Embryonic Organs – Kidney and Pancreas”. American Journal Transplantation (2004).
8. Ingber Donald. “3D Bioprinting of Living Tissues”. Wyss Institute, Harvard University, 9 Oct. (2020).
9. Kohn Donald., et al. “Induced Pluripotent Stem Cells (IPS)”. UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, Broad Stem Cell Research Center (2016).
10. Mary Kugler RN. “Learn How Cloning May Be Able to Cure Diseases One Day”. Verywell Health (2020).
11. Matas A J., et al. “OPTN/SRTR 2012 Annual Data Report: Kidney”. Wiley Online Library, John Wiley and Sons, Ltd (2014).
12. “Printing the Future: 3D Bioprinters and Their Uses”. Curious 23 (2017).
13. Ogle Brenda et al. “Fusion of approaches to the treatment of organ failure”. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 4 (2004): 74-77.
14. P Alexandrea. “Is 3D Bioprinting the Future of Tailor-Made Medicine?” 3Dnatives (2019).
15. Zhao Li-Fu., et al. “Key Challenges to the Development of Extracorporeal Bioartificial Liver Support Systems”. Hepatobiliary and Pancreatic Diseases International (2012).
16. "Reports from Guangzhou Medical University Highlight Recent Findings in Tissue Engineering (3d Bioprinting a Human Ipsc-derived Msc-loaded Scaffold for Repair of the Uterine Endometrium)”. Women's Health Weekly (2020): 483.
17. Hulick Kathryn. "Want to live forever?" Odyssey 2 (2015): 47.
18. "Reports from University of Maryland Add New Data to Findings in Bioprinting (Trophoblastendothelium Signaling Involves Angiogenesis and Apoptosis In a Dynamic Bioprinted Placenta Model)”. Women's Health Weekly (2019): 574.

Citation

Citation: Amyn Macknojia., et al. “Examining Bioprinting and its Effects on the Field of Medicine”. Acta Scientific Computer Sciences 2.6 (2021): 14-21.

Copyright

Copyright: © 2021 Amyn Macknojia., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.